Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Novartis AG (NOVN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
82.28 -0.04    -0.05%
15:12:00 - Delayed Data. Currency in CHF ( Disclaimer )
  • Volume: 2,130,679
  • Bid/Ask: 82.28 / 82.29
  • Day's Range: 81.80 - 82.88
Type:  Equity
Market:  Switzerland
ISIN:  CH0012005267 
VALOR:  1200526
Novartis 82.28 -0.04 -0.05%
RankUsernameTotalClosedWinningWin %Chg. %
1Ramon Guache33266.67+18.75%
2paris kariotis111100+15.17%
3Pascal Demierre111100+12.84%
4ALBERTO FERNANDEZ111100+12.5%
5Saverio Marulli111100+11.32%
6Marcello Breschi111100+9.1%
7Thomas Tsiavos222100+8.77%
8George Mueller111100+8.5%
9Daniel Gheorghe222100+8.14%
10Борис Пехов111100+7.85%
11Yves Bühler111100+7.77%
12Thierry Debus111100+7.7%
13Kaushik Shah333100+7.57%
14Alexandre Caillet111100+7.51%
15Stelios Vogiatzopoulos111100+7.26%
16Salvis Lapins111100+7.06%
17Riccardo Dinaro111100+7.03%
18Dmitry Devin111100+6.8%
19Eugene Esselaar111100+6.53%
20Arpad Drszabadfi111100+6.27%
21Alex Rummel111100+6.1%
22Ribero Cortez111100+6.1%
23Giuseppe Marsella222100+6.06%
24Caro Toinou111100+5.69%
25André van Duren111100+5.43%
26Sorawit Chan111100+5.43%
27Robin Selm111100+5.18%
28Markus Eberhart111100+5.02%
29Сагит Ибрагимов111100+4.94%
30Andrés Caldelari111100+4.73%
31Louis Siamos111100+4.64%
32Constantino Halkias111100+4.6%
33Filipe Serrano111100+4.6%
34Rob Schie111100+4.51%
35Alejandro souto111100+4.46%
36Konstantin Neykov111100+4.45%
37Dominik Heumann111100+4.35%
38Naghmeh Jalali111100+4.26%
39Eitan Kahnim111100+4.19%
40fred renoir111100+4.18%
41Jose Maria Loinaz Jaime111100+4.08%
42Hugues Privé111100+4.05%
43Christian Müller111100+4.02%
44Kil Ni111100+3.91%
45Daniel Scholla111100+3.62%
46pierre jouvelot111100+3.47%
47jachy josh111100+3.28%
48Tiberio Mihail111100+3.24%
49Massimo Cavalletti111100+3.17%
50Maor Shoham111100+3.14%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVN Comments

Write your thoughts about Novartis AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Lee Taylor
Lee Taylor Dec 01, 2021 10:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Novartis is trading at a value last seen in 2018; the funds released from a Sandoz divestment need to be directed towards further patient innovation from this Swiss Pharma major …
Lukas Bednall
Lukas Bednall Sep 28, 2021 15:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hi Guys, I have been invested in Novartis for 5 years and have closely followed the pharmaceutical industry for years. I have been very disappointed with the returns and am looking to transfer my portfolio into riskier assets. Upon research, I think I may have found an even better pharmaceutical company going by the name of SpectrumX. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trials for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email